← Open Payments lookup

KEITH WATTS: Open Payments

NPI 1710432190 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,845 in 140 payments from 19 companies in 2025. Trend: 2023 $2,945 · 2024 $3,499 · 2025 $2,845

Food & beverage: $2,845
CompanyPaymentsAmount
Alkermes, Inc.21$497
ABBVIE INC.25$444
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$368
Neurocrine BioSciences, Inc.11$294
Corium, LLC11$241
Otsuka America Pharmaceutical, Inc.7$152
Vanda Pharmaceuticals Inc.10$149
Indivior Inc.4$129
Takeda Pharmaceuticals U.S.A., Inc.6$105
Janssen Pharmaceuticals, Inc5$88

Products named: ARISTADA, VRAYLAR, CAPLYTA, INGREZZA, Azstarys, REXULTI, FANAPT, SUBLOCADE.

Industry payments across AL — which companies pay providers there.